Although multiple mediators, including interleukin-646, G-protein-coupled receptors47, Toll-like receptors48, and microRNAs49, were identified to regulate STAT3 signaling in cancer, we have a limited understanding of the upstream regulatory mechanisms of STAT3 in LSCC. Here, STAT3 is linked to cancer.